Alpine Acquisition Corp. REVE 深 沪
已收盘 04-10 16:00:00 美东时间
10.54
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 10.54
- 总市值 1.43亿
- 52周最高 16.56
- 市盈率 静 23.46
- 换手率 0.00%
- 52周最低 8.565
- 委 比 0.00%
- 总股本 1355.00万
- 历史最高 16.56
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.565
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多General Dynamics Reports Third-Quarter 2025 Financial Results
Revenue $12.9 billion, up 10.6% from year-ago quarter Diluted EPS $3.88, up 15.8% from year-ago quarter $2.1 billion cash from operating activities, 199% of net earnings Very strong order ac...
10-24 19:00
IBM RELEASES THIRD-QUARTER RESULTS
Acceleration in revenue growth and profit across all segments; Raises outlook for full-year revenue growth and free cash flow ARMONK, N.Y., Oct. 22, 2025 /PRNewswire/ -- IBM (NYSE: IBM) toda...
10-23 04:08
ROYAL CARIBBEAN REVEALS SUMMER 2027 ADVENTURES TO ALASKA
Vacationers are in for an action-packed lineup from Anthem of the Seas and its first-ever Cruisetour experiences to more ways to explore on Quantum, Serenade and Voyager of the Seas MIAMI, O...
10-22 23:34
Why Is Taysha Gene Therapies Stock Falling Friday?
Taysha Gene Therapies shares fall after regaining full rights to Rett syndrome drug TSHA-102 and finalizing FDA alignment for pivotal trial.
10-18 00:44
Home Federal Bancorp's Board of Directors Authorizes Stock Repurchase Program
SHREVEPORT, La., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Home Federal Bancorp, Inc. of Louisiana (the "Company") (NASDAQ:HFBL), the holding company for Home Federal Bank, announced today that its Board of Directors at their
10-16 04:34
Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks
Tvardi Therapeutics stock falls as Phase 2 IPF trial of TTI-101 shows no significant FVC improvement, with high variability and placebo response.
10-14 02:23
ChipMOS REPORTS 10.5% YoY INCREASE IN SEPTEMBER 2025 REVENUE; 3Q25 REVENUE INCREASES 7.1% QoQ
HSINCHU, Oct. 9, 2025/PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourc...
10-09 18:00
Merck Drug WINREVAIR Cuts Risk Of Worsening Pulmonary Hypertension By 76% In Phase 3 Trial
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR™ (sotatercept-csrk) versus placebo (both in combination
09-30 16:23
CHIPOTLE REVEALS RED CHIMICHURRI AS NEXT STEP IN MENU INNOVATION
In response to guest passion around its dips and sauces, Chipotle is introducing Red Chimichurri on Tuesday, September 30 as a limited-time menu item in the U.S. and Canada Prepared in-resta...
09-29 19:53
ChipMOS REPORTS 6.3% INCREASE IN AUGUST 2025 REVENUE MoM
HSINCHU, Sept. 10, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outso...
09-10 18:00
